J. Voorberg et al., INTRACELLULAR RETENTION OF A FACTOR-VIII PROTEIN WITH AN ARG(2307)-]GLN MUTATION AS A CAUSE OF HEMOPHILIA-A, Biochemical journal, 318, 1996, pp. 931-937
Substitution of Arg(2307) by Gin in factor VIII has been found to be a
ssociated with mild to moderate haemophilia A [Gitschier, Wood, Shuman
and Lawn (1986) Science 232, 1415-1416]. We have introduced this part
icular point mutation into a B-domain-deleted factor VIII cDNA and exp
ressed the modified cDNA in C127 cells. Cells expressing the resulting
protein, termed des-(868-1562)-factor VIII-R2307Q, were compared with
those expressing the previously characterized des-(868-1562)-factor V
III. No immunoreactive material could be detected in the conditioned m
edium of cells transfected with des-(868-1562)-factor VIII-R2307Q cDNA
using assays specific for the factor VIII light chain and the factor
VIII heavy chain. Analysis of metabolically labelled cells transfected
with des-(868-1562)-factor VIII-R2307Q cDNA revealed that this mutant
protein is synthesized at a level similar to des-(868-1562)-factor VI
II. In contrast to des-(868-1562)-factor VIII, metabolically labelled
des-(868-1562)-factor VIII-R2307Q was not encountered in the condition
ed medium of the transfected cells, indicating that the mutant protein
is not secreted from the cell. Inspection of the intracellular locali
zation of the two proteins in the cell employing morphological analysi
s, endoglycosidase H and experiments with inhibitors of glucosidases I
and II was consistent with focalization of des-(868-1562)-factor VIII
and des-(868-1562)-factor VIII-R2307Q in the endoplasmic reticulum. T
aken together, our data indicate that the Arg(2307) --> Gln mutation r
esults in aberrant intracellular trafficking of factor VIII, which may
explain the low levels of factor WI antigen in the plasma of haemophi
lia A patients that carry this particular point mutation.